src: 3rxiuf34c6812zu916107ws7-wpengine.netdna-ssl.com
Romosozumab (AMG 785) is a humanized monoclonal antibody that targets sclerostin for the treatment of osteoporosis.
Romosozumab was originally discovered by Celltech (now owned by UCB). Celltech entered in a partnership with Amgen in 2002 for the product's development.
In 2016 results from 12 months of a clinical study were reported.
Some results from the FRAME and ARCH clinical studies were reported on in 2017.
Video Romosozumab
References
Source of article : Wikipedia
0 Comments